Your session is about to expire
← Back to Search
Study Summary
This trial will help to develop a diagnostic protocol for children who are at high risk for autism, in order to improve early intervention program screening.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My child is 16-30 months old, scored ≥8 on the MCHAT-R, and was referred to the clinic by 33 months.My child is not older than 33 months.My child is exposed to English at home or in their care setting.
- Group 1: Families with children enrolled in BCW with suspected diagnosis of autism
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available to those interested in participating in this clinical trial?
"According to data from clinicaltrials.gov, this experiment is currently in the process of recruitment. The initial posting was made on 16th June 2022 and last revised 17th June 2022."
Can elderly individuals aged 60 or older join this research initiative?
"According to the prerequisites for participation, infants and toddlers aged 16 months to 36 months are eligible."
What types of individuals are ideal candidates for this experiment?
"This clinical trial will be accepting one-hundred autistic children between the ages of 16 to 36 months old. Most significantly, applicants must meet the following criteria: A score ≥ 8 on MCHAT-R assessments; a parent or guardian with basic English proficiency and internet access; exposure to English at home or in out-of-home care (e.g., childcare setting); documentation of an MCHAT-R high risk failed score (≥ 8) in their referral; and lastly, referring BCW provider from any of the three targeted districts participating in this pilot study."
How many participants are involved in this research endeavor?
"Affirmative. Clinicaltrials.gov reveals that enrollment for this trial, which was initially published on June 16th 2022 is still in progress. This study calls for 100 participants at a single medical site."
What are the projected results from this research endeavor?
"The primary aim of this trial, to be monitored over the course of one year, is assessing how many participants successfully complete the Early Diagnostic Response Model (EDRM) study. Secondary objectives include evaluating parent satisfaction with EDRM assessment through a Likert-scale survey ranging from 1-5 and tracking high-risk referral assessments completed via telehealth protocol, as well as measuring BCW provider Early Intervention Coordinator satisfaction with EDRM pilot surveys every three months."
Share this study with friends
Copy Link
Messenger